Estados financieros detallados de Fulgent Genetics, Inc. (FLGT): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Fulgent Genetics, Inc. registró ingresos de $322.7M en el último ejercicio fiscal, con un CAGR de 5 años del -5.2%.
Márgenes de los últimos 12 meses: margen bruto 35.6%, margen operativo -37.1%, margen neto -26.0%.
Al precio actual de $21.63, FLGT presenta beneficios negativos (P/E no significativo) y un ROE del -7.87%. La capitalización bursátil es de $614M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $18.3M | $18.7M | $21.4M | $32.5M | $421.7M | $992.6M | $619.0M | $289.2M | $283.5M | $322.7M |
| Coste de Ventas | $6.7M | $8.6M | $10.7M | $14.1M | $89.8M | $215.5M | $252.1M | $184.8M | $176.3M | $191.8M |
| Beneficio Bruto | $11.6M | $10.2M | $10.7M | $18.4M | $331.9M | $777.1M | $366.9M | $104.5M | $107.2M | $130.9M |
| I+D | $3.6M | $4.2M | $5.5M | $6.5M | $11.6M | $24.2M | $28.9M | $41.4M | $48.8M | $53.9M |
| Generales y Administrativos | $7.1M | $9.4M | $10.2M | $12.3M | $30.2M | $75.2M | $150.0M | $130.5M | $124.4M | $160.0M |
| Gastos Operativos | $10.6M | $13.6M | $15.7M | $18.8M | $41.7M | $101.1M | $188.4M | $300.0M | $181.1M | $222.0M |
| Beneficio Operativo | $919000 | -$3.5M | -$5.1M | -$428000 | $290.2M | $676.0M | $178.5M | -$195.5M | -$73.9M | -$91.1M |
| EBITDA | $2.1M | -$1.8M | -$2.9M | $1.7M | $293.1M | $692.0M | $217.7M | -$147.5M | -$26.9M | -$45.8M |
| Gastos por Intereses | $5.4M | 0 | 0 | 0 | 0 | 0 | $1.0M | $488000 | $170000 | $75000 |
| Beneficio Antes de Impuestos | -$4.5M | -$3.0M | -$4.6M | -$368000 | $286.8M | $681.0M | $184.0M | -$174.1M | -$52.0M | -$70.0M |
| Impuestos | $920000 | -$1.0M | $36000 | $43000 | $72.5M | $174.8M | $42.1M | $1.2M | -$8.1M | -$8.4M |
| Beneficio Neto | -$5.3M | -$2.5M | -$5.6M | -$411000 | $214.3M | $507.4M | $143.4M | -$167.8M | -$42.7M | -$60.5M |
| BPA | $-0.30 | $-0.15 | $-0.25 | $-0.02 | $9.44 | $17.13 | $4.76 | $-5.63 | $-1.41 | $-1.97 |
| BPA Diluido | $-0.30 | $-0.15 | $-0.25 | $-0.02 | $8.91 | $16.26 | $4.63 | $-5.63 | $-1.41 | $-1.97 |
| Acciones en Circulación (Diluidas) | $17.7M | $17.7M | $18.0M | $18.7M | $24.1M | $31.0M | $31.0M | $29.8M | $30.2M | $30.8M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $84.1M | $83.3M | $71.1M | $85.4M |
| Beneficio Bruto | $35.5M | $32.6M | $21.5M | $25.7M |
| Beneficio Operativo | -$15.3M | -$36.2M | -$34.6M | -$33.9M |
| EBITDA | -$77000 | -$23.0M | -$20.0M | -$22.0M |
| Beneficio Neto | -$6.6M | -$23.4M | -$24.8M | -$29.5M |
| BPA | $-0.21 | $-0.76 | $-0.80 | $-1.05 |
| BPA Diluido | $-0.21 | $-0.76 | $-0.80 | $-1.05 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $7.9M | $6.5M | $6.7M | $12.0M | $87.4M | $164.9M | $79.5M | $97.5M | $55.1M | $50.2M |
| Inversiones a Corto | $38.6M | $34.9M | $30.7M | $16.3M | $211.9M | $285.6M | $446.7M | $326.7M | $203.0M | $285.9M |
| Cuentas por Cobrar | $4.4M | $4.1M | $6.2M | $7.2M | $204.1M | $143.3M | $75.1M | $57.4M | $77.0M | $91.6M |
| Inventario | $322000 | $231000 | $314000 | $277000 | $16.5M | $12.2M | $4.3M | $5.8M | $8.4M | $10.6M |
| Activos Corrientes | $50.8M | $45.4M | $43.4M | $37.1M | $523.6M | $612.0M | $627.9M | $507.8M | $353.6M | $550.5M |
| Inmovilizado Material | $6.2M | $7.3M | $6.4M | $8.6M | $40.2M | $62.3M | $81.4M | $83.5M | $105.5M | $112.5M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | $50.9M | $143.0M | $22.1M | $22.1M | $25.1M |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | $35.9M | $150.6M | $143.1M | $135.0M | $133.3M |
| Activos Totales | $58.0M | $57.0M | $55.0M | $88.8M | $700.5M | $1.28B | $1.39B | $1.24B | $1.22B | $1.21B |
| Cuentas por Pagar | $2.8M | $2.1M | $1.3M | $1.6M | $26.5M | $20.5M | $23.1M | $15.4M | $18.4M | $18.7M |
| Deuda a Corto | 0 | 0 | 0 | 0 | $15.0M | $21.3M | $20.6M | $1.2M | $412000 | $476000 |
| Pasivos Corrientes | $3.6M | $2.9M | $2.7M | $3.7M | $130.1M | $105.3M | $88.1M | $73.0M | $72.9M | $85.0M |
| Deuda a Largo | 0 | 0 | 0 | 0 | 0 | 0 | $3.4M | $3.0M | $2.5M | $2.0M |
| Pasivos Totales | $3.6M | $2.9M | $2.7M | $6.0M | $131.1M | $112.8M | $116.2M | $102.0M | $90.8M | $106.8M |
| Reservas | -$55.2M | -$57.7M | -$63.0M | -$63.4M | $150.9M | $657.6M | $801.0M | $633.2M | $590.5M | $530.0M |
| Patrimonio Neto | $54.5M | $54.0M | $52.3M | $82.8M | $569.4M | $1.16B | $1.27B | $1.14B | $1.13B | $1.11B |
| Deuda Total | 0 | 0 | 0 | $2.7M | $15.9M | $21.3M | $38.9M | $15.3M | $8.5M | $7.7M |
| Deuda Neta | -$46.5M | -$41.4M | -$37.4M | -$25.6M | -$283.5M | -$429.2M | -$487.3M | -$408.9M | -$249.6M | -$328.4M |
| Capital Circulante | $47.3M | $42.4M | $40.6M | $33.4M | $393.5M | $506.6M | $539.8M | $434.8M | $280.7M | $465.5M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $117.6M | $50.2M | $23.4M | $26.3M |
| Activos Totales | $1.21B | $1.21B | $1.16B | $1.09B |
| Pasivos Totales | $93.8M | $106.8M | $112.2M | $93.2M |
| Patrimonio Neto | $1.13B | $1.11B | $1.05B | $1.00B |
| Deuda Total | $7.5M | $7.7M | $9.9M | $9.4M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$5.4M | -$2.5M | -$5.6M | -$411000 | $214.3M | $506.2M | $141.9M | -$175.2M | -$43.8M | -$61.6M |
| Amortizaciones | $1.2M | $1.7M | $2.2M | $2.5M | $3.0M | $11.0M | $32.7M | $26.1M | $24.9M | $24.1M |
| Compensación en Acciones | $4.7M | $2.1M | $2.3M | 0 | $8.2M | $15.9M | $32.6M | $42.9M | $44.5M | $39.6M |
| Cambio en Capital Circulante | -$1.9M | -$714000 | -$1.2M | -$915000 | -$91.5M | -$2.7M | $2.0M | $2.8M | -$7.2M | -$117.6M |
| Flujo de Caja Operativo | $4.4M | $1.3M | -$675000 | $5.5M | $140.6M | $538.6M | $253.5M | $27.0M | $21.1M | -$101.6M |
| Inversiones (CapEx) | -$3.8M | -$5.4M | -$2.8M | -$1.2M | -$36.5M | -$23.8M | -$18.8M | -$22.2M | -$40.3M | -$22.6M |
| Adquisiciones | $10000 | $2.5M | $510000 | 0 | -$2.6M | -$61.9M | -$182.7M | -$399000 | 0 | $3.8M |
| Recompra de Acciones | 0 | 0 | 0 | -$21000 | -$62000 | -$4.2M | -$76.1M | -$27.8M | -$3.1M | -$13.9M |
| Dividendos Pagados | -$4.6M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | $617000 | -$4.0M | -$3.5M | $4.3M | $104.1M | $514.7M | $234.7M | $4.8M | -$19.3M | -$124.2M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | $11.1M | -$78.1M | $7.1M | -$23.8M |
| Inversiones (CapEx) | -$6.0M | -$5.0M | -$5.2M | -$3.9M |
| Flujo de Caja Libre | $5.1M | -$83.1M | $1.9M | -$27.6M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $9.7M | $9.3M | 0 | $18.5M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | +2.5% | +14.0% | +52.3% | +1196.5% | +135.4% | -37.6% | -53.3% | -2.0% | +13.8% |
| Crecimiento Beneficio Neto (anual) | | +53.1% | -123.4% | +92.7% | +52243.6% | +136.7% | -71.7% | -217.0% | +74.6% | -41.7% |
| Crecimiento BPA (anual) | | +50.0% | -66.7% | +92.0% | +47300.0% | +81.5% | -72.2% | -218.3% | +75.0% | -39.7% |
| Cambio en Acciones (anual) | | +0.4% | +1.3% | +4.1% | +28.6% | +28.8% | -0.0% | -3.8% | +1.5% | +1.8% |
| Crecimiento FCF (anual) | | -752.4% | +12.9% | +223.6% | +2301.8% | +394.4% | -54.4% | -98.0% | -501.5% | -545.1% |
| Margen Bruto | 63.2% | 54.3% | 49.9% | 56.6% | 78.7% | 78.3% | 59.3% | 36.1% | 37.8% | 40.6% |
| Margen Operativo | 5.0% | -18.6% | -23.7% | -1.3% | 68.8% | 68.1% | 28.8% | -67.6% | -26.1% | -28.2% |
| Margen EBITDA | 11.4% | -9.4% | -13.6% | 5.2% | 69.5% | 69.7% | 35.2% | -51.0% | -9.5% | -14.2% |
| Margen Neto | -29.3% | -13.4% | -26.3% | -1.3% | 50.8% | 51.1% | 23.2% | -58.0% | -15.1% | -18.8% |
| Margen FCF | 3.4% | -21.5% | -16.4% | 13.3% | 24.7% | 51.9% | 37.9% | 1.7% | -6.8% | -38.5% |
| Tasa Impositiva Efectiva | -20.6% | 33.8% | -0.8% | -11.7% | 25.3% | 25.7% | 22.9% | -0.7% | 15.7% | 12.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $0.03 | $-0.23 | $-0.20 | $0.23 | $4.33 | $16.62 | $7.58 | $0.16 | $-0.64 | $-4.04 |
| Dividendo por Acción | $0.26 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $17.7M | $17.7M | $18.0M | $18.7M | $22.7M | $29.4M | $30.1M | $29.8M | $30.2M | $30.8M |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | -7.87% |
| Rentabilidad sobre capital invertido | -11.05% |
| Rentabilidad sobre activos | -7.75% |
| Margen bruto | 35.58% |
| Margen operativo | -37.08% |
| Margen neto | -26.05% |
Salud financiera
| Deuda / Patrimonio | 0.01 |
| Ratio corriente | 6.34 |
| Piotroski F-Score | 4 |
| Altman Z-Score | 5.63 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -38.57 | -29.20 | -12.68 | -645.00 | 5.52 | 5.87 | 6.26 | -5.13 | -13.10 | -13.34 |
| P/VC | 3.75 | 1.44 | 1.09 | 2.92 | 2.08 | 2.55 | 0.71 | 0.76 | 0.49 | 0.73 |
| P/V | 11.19 | 4.15 | 2.67 | 7.42 | 2.80 | 2.98 | 1.45 | 2.98 | 1.97 | 2.51 |
| Margen Bruto | 63.2% | 54.3% | 49.9% | 56.6% | 78.7% | 78.3% | 59.3% | 36.1% | 37.8% | 40.6% |
| Margen Operativo | 5.0% | -18.6% | -23.7% | -1.3% | 68.8% | 68.1% | 28.8% | -67.6% | -26.1% | -28.2% |
| Margen Neto | -29.3% | -13.4% | -26.3% | -1.3% | 50.8% | 51.1% | 23.2% | -58.0% | -15.1% | -18.8% |